CMS proposed several changes to its Medicare billing standards July 12, including paying doctors for virtual visits and alleviating some of their administrative burden.
July 12, 2018 | Practice Management
A new survey from University of Utah Health revealed that most physicians feel responsible for educating patients about the cost of care but don’t believe they should be held accountable for it.
Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.
The U.S. Preventive Services Task Force (USPSTF) issued a Grade I recommendation for screening peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI), indicating current evidence is insufficient to recommend screening without signs or symptoms of disease.
Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the remaining 65 percent stake for $202 million in up-front cash.
A federal investigation into the potential overuse of primary prevention implantable cardioverter defibrillators (ICDs) appears to have made hospitals more judicious in their use of the devices, according to a study published July 3 in the Journal of the American Medical Association.
Health insurance does little to protect low-income families from crippling financial hardship when a relative has atherosclerotic cardiovascular disease (ASCVD), according to a study published July 3 in JAMA Cardiology.
The FDA’s rules preventing sexually active gay men from donating blood are discriminatory and based on outdated fears, a physician wrote in an op-ed piece for the Los Angeles Times.
CMS is taking public comments ahead of a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) meeting July 25 in which panelists will discuss procedural volume requirements for centers to begin and maintain a transcatheter aortic valve replacement (TAVR) program.
A company called Novoheart has created the first 3D heart organoid—a miniature version of the real thing—which contains a hollow chamber similar to one of the four in a normal human heart. According to a story published by Wired, these mini-hearts could be used to test the effects of drug treatments before expensive human trials are necessary.
Safety-net hospitals (SNHs) and smaller facilities were less likely to participate in the voluntary Bundled Payments for Care Improvement (BPCI) programs for cardiac services than larger centers with catheterization laboratories. These findings indicate that the outcomes observed from these programs may not be broadly applicable.
About a quarter of those who require insulin to treat diabetes use less than what is prescribed because of cost concerns, suggests a single-center study presented last week at the American Diabetes Association scientific sessions in Orlando.
A pair of point/counterpoint articles published online June 25 in JACC: Heart Failure debated whether the Hospital Readmissions Reduction Program (HRRP) has resulted in greater mortality for heart failure patients or whether those observations stem from incomplete or misconstrued evidence.
After a year of soul searching and strategic review, GE announced its move today to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt.
Two nonprofits in the Philadelphia area have joined forces to deliver personalized meals to Medicaid beneficiaries.
Jun 25, 2018 | Heart Failure
Just a week after Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program, CMS sent a letter to the hospital saying it will cut off funding for the program beginning Aug. 17.
Heart Failure, Healthcare Economics & Policy
Jun 22, 2018 | Heart Failure
Heart failure patients treated at hospitals with lower 30-day mortality rates also enjoy a survival benefit one, three and even five years later, suggesting a short-term risk-standardized mortality rate (RSMR) may deserve additional weight in CMS’s financial incentive programs.
Heart Failure, Healthcare Economics & Policy, Practice Management
A bill advancing through the California legislature seeks to remove soda, juice and chocolate milk as default options for kids’ meals and prevent them from being advertised alongside food marketed toward children.
Healthcare Economics & Policy, Lipids & Metabolic
Providers were just as likely to perform low-value coronary revascularizations after joining an accountable care organization (ACO), a new analysis found. Considering ACOs are designed to curb healthcare spending, these findings suggest their current setup doesn’t properly incentivize specialists to change their behavior.
Healthcare Economics & Policy, Practice Management, Coronary Intervention & Surgery
The National Institutes of Health (NIH) has shut down a $100 million study designed to settle the question over whether one alcoholic beverage per day is part of a heart-healthy diet.
Healthcare Economics & Policy
A host of medical devices—including imaging equipment, pacemakers and electrocardiographs—are included in the list of Chinese products that will be hit with a 25 percent tariff beginning July 6, the U.S. government announced Friday.
Healthcare Economics & Policy